Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2 March 2012
|
| In: |
British journal of clinical pharmacology
Year: 2012, Jahrgang: 74, Heft: 5, Pages: 854-863 |
| ISSN: | 1365-2125 |
| DOI: | 10.1111/j.1365-2125.2012.04261.x |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1111/j.1365-2125.2012.04261.x Resolving-System, kostenfrei, Volltext: https://doi.org/10.1111/j.1365-2125.2012.04261.x |
| Verfasserangaben: | Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576420353 | ||
| 003 | DE-627 | ||
| 005 | 20220814164444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180615s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1365-2125.2012.04261.x |2 doi | |
| 035 | |a (DE-627)1576420353 | ||
| 035 | |a (DE-576)506420353 | ||
| 035 | |a (DE-599)BSZ506420353 | ||
| 035 | |a (OCoLC)1341011815 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Grün, Barbara |e VerfasserIn |0 (DE-588)1161226311 |0 (DE-627)1024632121 |0 (DE-576)506420922 |4 aut | |
| 245 | 1 | 0 | |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine |c Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus |
| 264 | 1 | |c 2 March 2012 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.06.2018 | ||
| 700 | 1 | |a Merkel, Ulrike Hannah |d 1984- |e VerfasserIn |0 (DE-588)1025370821 |0 (DE-627)722174934 |0 (DE-576)370274970 |4 aut | |
| 700 | 1 | |a Riedel, Klaus-Dieter |e VerfasserIn |0 (DE-588)1034229605 |0 (DE-627)745128432 |0 (DE-576)381859460 |4 aut | |
| 700 | 1 | |a Weiß, Johanna |e VerfasserIn |0 (DE-588)1050230906 |0 (DE-627)783666322 |0 (DE-576)404441114 |4 aut | |
| 700 | 1 | |a Mikus, Gerd |e VerfasserIn |0 (DE-588)110903137 |0 (DE-627)691097941 |0 (DE-576)336988710 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of clinical pharmacology |d Oxford : Wiley-Blackwell, 1974 |g 74(2012), 5, Seite 854-863 |h Online-Ressource |w (DE-627)306585995 |w (DE-600)1498142-7 |w (DE-576)091140056 |x 1365-2125 |7 nnas |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine |
| 773 | 1 | 8 | |g volume:74 |g year:2012 |g number:5 |g pages:854-863 |g extent:10 |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1365-2125.2012.04261.x |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1365-2125.2012.04261.x |x Resolving-System |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180615 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 110903137 |a Mikus, Gerd |m 110903137:Mikus, Gerd |d 910000 |d 910100 |e 910000PM110903137 |e 910100PM110903137 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 1050230906 |a Weiß, Johanna |m 1050230906:Weiß, Johanna |d 910000 |d 910100 |e 910000PW1050230906 |e 910100PW1050230906 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1034229605 |a Riedel, Klaus-Dieter |m 1034229605:Riedel, Klaus-Dieter |d 910000 |d 910100 |e 910000PR1034229605 |e 910100PR1034229605 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1025370821 |a Merkel, Ulrike Hannah |m 1025370821:Merkel, Ulrike Hannah |d 910000 |d 910100 |e 910000PM1025370821 |e 910100PM1025370821 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1161226311 |a Grün, Barbara |m 1161226311:Grün, Barbara |d 910000 |d 950000 |d 950900 |e 910000PG1161226311 |e 950000PG1161226311 |e 950900PG1161226311 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1576420353 |e 3012766170 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1576420353","name":{"displayForm":["Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2 March 2012"}],"id":{"doi":["10.1111/j.1365-2125.2012.04261.x"],"eki":["1576420353"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"language":["eng"],"title":[{"title_sort":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine","title":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine"}],"person":[{"given":"Barbara","role":"aut","family":"Grün","display":"Grün, Barbara"},{"display":"Merkel, Ulrike Hannah","role":"aut","given":"Ulrike Hannah","family":"Merkel"},{"display":"Riedel, Klaus-Dieter","family":"Riedel","given":"Klaus-Dieter","role":"aut"},{"role":"aut","given":"Johanna","family":"Weiß","display":"Weiß, Johanna"},{"family":"Mikus","given":"Gerd","role":"aut","display":"Mikus, Gerd"}],"relHost":[{"title":[{"subtitle":"BJCP","title":"British journal of clinical pharmacology","title_sort":"British journal of clinical pharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1974 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"BJCP"}],"note":["Gesehen am 20.03.2014"],"part":{"text":"74(2012), 5, Seite 854-863","extent":"10","volume":"74","pages":"854-863","issue":"5","year":"2012"},"id":{"doi":["10.1111/(ISSN)1365-2125"],"eki":["306585995"],"zdb":["1498142-7"],"issn":["1365-2125"]},"origin":[{"dateIssuedDisp":"1974-","dateIssuedKey":"1974","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford ; Oxford ; Oxford [u.a.]"}],"disp":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidineBritish journal of clinical pharmacology","recId":"306585995"}],"note":["Gesehen am 15.06.2018"]} | ||
| SRT | |a GRUENBARBACONTRIBUTI2201 | ||